Publications by authors named "F Grude"

Claim this Profile
S
Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019.
Fiona Y-V Pham, Emmanuelle Jacquet, Amina Taleb, Adrien Monard, Ghania Kerouani-Lafaye

Int J Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to innovation through the national early access program and clinical trials for patients with malignant melanoma.
Claire Christen, Laetitia Belgodère, Bernard Guillot, Céline Jumeau, Annie Lorence

Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Knowledge of geriatric oncology in nursing homes: survey among healthcare professionals working in nursing homes in Pays-de-la-Loire.].
Marianne Le Rhun, Véronique Bourcy, Françoise Grudé, Jean-Claude Maupetit, Laure De Decker

Geriatr Psychol Neuropsychiatr Vieil· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Clinical Trials in Onco-haematology: A New Method Based on Risk Analysis and Multidisciplinarity.
J Lapière, C Christen, G Kerouani-Lafaye, A Monard, F Turcry, F Grude

Ther Innov Regul Sci· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years.
Emmanuelle Jacquet, Ghania Kerouani-Lafaye, Francoise Grude, Sergio Goncalves, Annie Lorence

Eur J Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis